HHR Asset Management’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding HCAT
FLAM
HHR Asset Management's HCAT Position: Q2 2022 in Review
HHR Asset Management sold out of Health Catalyst (HCAT) in Q2 2022, closing a stake of 227,318 shares — an estimated $5.94M sold.
HHR Asset Management first reported a position in HCAT in Q3 2020 and held it in 7 quarters. The position peaked at $18.5M in Q4 2020. 180 funds tracked by Wall St. Rank hold HCAT as of Q2 2022.
- HHR Asset Management reported no remaining Health Catalyst position as of Q2 2022 after selling out during the quarter.
- HHR Asset Management sold 227,318 Health Catalyst shares in Q2 2022, an estimated $5.94M.
- HHR Asset Management first reported a position in Health Catalyst in Q3 2020 and held it in 7 quarters.
- HHR Asset Management's Health Catalyst position peaked at $18.5M in Q4 2020.
- 180 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2022.
Based on HHR Asset Management's 13F filing for Q2 2022.